| 5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety. | |
| | |
MedLine Citation:
|
PMID: 10501445 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The serotonergic system is considered as a neuromodulatory system interacting with other neurotransmissions in the brain and participating in the elaboration of an adapted response of the central nervous system to external stimuli. Indeed, serotonin is involved in a large number of physiological events, such as temperature regulation, sleep, learning and memory, behaviour, sexual function, hormonal secretions and immune activity, and in parallel, it is also implicated in pathological disorders particularly in stress, anxiety, aggressivity and depression. At least 14 different types of serotonin receptors mediate serotonergic activity and among them, serotonin-1B receptors play an important role in the control of the serotonergic function. Serotonin-1B receptors are autoreceptors localized on serotonergic neuron terminals (varicosities) where they inhibit the evoked release of serotonin and its biosynthesis; they are also heteroreceptors located on non-serotonergic terminals, where they inhibit the release of the corresponding neurotransmitters (acetylcholine, GABA, noradrenaline, etc.). 5-Hydroxytryptamine-moduline, an endogenous tetrapeptide (Leu-Ser-Ala-Leu) recently isolated and characterized from rat and bovine brain extracts, was shown to specifically interact with serotonin1B receptors as an allosteric modulator having antagonistic properties in vitro and in vivo. Immuncytochemical studies using specific polyclonal anti-peptide antibodies have shown that this peptide is distributed heterogeneously in mouse brain and located in areas which also contain serotonin-1B receptors. Moreover, the content of these cerebral tissues in 5-hydroxytryptamine-moduline is affected by stress. In the present work, polyclonal anti-5-hydroxytryptamine-moduline antibodies were administered to mice via intracerebroventricular injections to study the in vivo effects of a lowering (or suppression) of this neuropeptide in the central nervous system. The inactivation of the peptide by the specific antibodies significantly modified the behaviour of the animals in two behavioural tests, the open-field and elevated plus-maze, known to be animal models related to anxiety behaviour. Treated mice displayed behaviour consistent with an anxiolytic effect of the antibody, suggesting a potential role of 5-hydroxytryptamine-moduline in the control of anxiety. |
| | |
Authors:
|
B Grimaldi; A Bonnin; M P Fillion; N Prudhomme; G Fillion |
Related Documents
:
|
6303355 - Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal rece... 10582215 - Pre- and postsynaptic mechanisms of the involvement of amygdaloid complex serotonin in ... 15208825 - The next generation of chemotherapy-induced nausea and vomiting prevention and control:... 3039115 - Preclinical evaluation of mcn-5707 as a potential antidepressant. 14729255 - Localization of dopamine d1-receptor to a-type horizontal cells in the rabbit retina by... 1310115 - Synthesis, antinociceptive activity, and opioid receptor profiles of substituted trans-... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Neuroscience Volume: 93 ISSN: 0306-4522 ISO Abbreviation: Neuroscience Publication Date: 1999 |
Date Detail:
|
Created Date: 1999-12-09 Completed Date: 1999-12-09 Revised Date: 2003-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 7605074 Medline TA: Neuroscience Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1223-5 Citation Subset: IM |
Affiliation:
|
Unité de pharmacologie neuroimmunoendocrinienne, Institut Pasteur, Paris, France. grimaldi@pasteur.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antibodies / pharmacology Anxiety / metabolism* Behavior, Animal Brain Chemistry / physiology* Injections, Intraventricular Maze Learning Mice Motor Activity Neuropeptides / immunology, metabolism* Oligopeptides / immunology, metabolism* Serotonin / metabolism Synaptic Transmission / physiology |
| Chemical | |
Reg. No./Substance:
|
0/5-HT-moduline; 0/Antibodies; 0/Neuropeptides; 0/Oligopeptides; 50-67-9/Serotonin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippoca...
Next Document: Interaction between intracellular tetanization and pairing-induced long-term synaptic plasticity in ...